Institutional Ownership
Tenax Therapeutics Inc
CUSIP 88032L605COM NEWTENXQ1 2026
13D / 13G Filings
43
Schedule 13D/13G on record
Beneficial Filers
22
Distinct reporting persons
Largest Stake
21.2%
Max % of class reported
Institutional Holders
76
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
43 filings · latest Mar 10, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 10, 2026 | Christopher Thomas Giordano | 13D | 6.8% | — | SEC |
| 2 | Mar 9, 2026 | Logos Global Management LP | 13G | 9.9% | — | SEC |
| 3 | Feb 17, 2026 | Dellora Investments Master Fund LP | 13G/A | 6.4% | 401.1K | SEC |
| 4 | Feb 17, 2026 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.9% | 693.0K | SEC |
| 5 | Feb 17, 2026 | Rtw Investments, LP | 13G/A | 9.9% | 651.0K | SEC |
| 6 | Feb 17, 2026 | Perceptive Advisors LLC | 13G/A | 9.1% | 569.3K | SEC |
| 7 | Feb 17, 2026 | Lind Global Fund II LP | 13G/A | 11.0% | 442.5K | SEC |
| 8 | Feb 17, 2026 | Biotechnology Value Fund L P | 13G/A | 10.0% | 768.2K | SEC |
| 9 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 6.8% | 423.4K | SEC |
| 10 | Feb 12, 2026 | Morgan Stanley | 13G | 9.6% | 596.4K | SEC |
33 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Tenax Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 1.82M | $29.07M |
| 2 | Venrock Adviser, LLC | 1.68M | $26.79M |
| 3 | Perceptive Advisors LLC | 1.45M | $23.15M |
| 4 | Ikarian Capital, LLC | 1.02M | $16.27M |
| 5 | Stonepine Capital Management, LLC | 975.2K | $15.59M |
| 6 | Logos Global Management LP | 625.0K | $9.99M |
| 7 | Morgan Stanley | 596.6K | $9.54M |
| 8 | Velan Capital Investment Management LP | 583.3K | $9.33M |
| 9 | Adage Capital Partners Gp, L.L.C. | 540.1K | $8.64M |
| 10 | Point72 Asset Management, L.P. | 534.0K | $8.54M |